Moreover, SIRT3 overexpression also promotes ROS and apoptosis induced by the HCC therapy regorafenib, a multiple kinase inhibitor and mitochondrial toxicant, by accelerating mitochondrial depolarization induced by regorafenib and inducing mitochondrial dysfunction through impaired ETC function [196]. The gene discussed is SIRT3; the disease is hepatocellular carcinoma.